share_log

The Recent 9.7% Gain Must Have Brightened CEO Wei He's Week, Liaoning He Eye Hospital Group Co., LTD.'s (SZSE:301103) Most Bullish Insider

The Recent 9.7% Gain Must Have Brightened CEO Wei He's Week, Liaoning He Eye Hospital Group Co., LTD.'s (SZSE:301103) Most Bullish Insider

最近9.7%的漲幅一定讓首席執行官魏和的本週大放異彩,遼寧和眼科醫院集團有限公司s (SZSE: 301103) 最看漲的內幕人士
Simply Wall St ·  05/08 18:45

Key Insights

關鍵見解

  • Insiders appear to have a vested interest in Liaoning He Eye Hospital Group's growth, as seen by their sizeable ownership
  • 51% of the business is held by the top 5 shareholders
  • Institutional ownership in Liaoning He Eye Hospital Group is 12%
  • 從遼寧和眼科醫院集團的龐大所有權來看,業內人士似乎對遼寧和眼科醫院集團的增長有既得利益
  • 51% 的業務由前五名股東持有
  • 遼寧和眼科醫院集團的機構所有權爲12%

To get a sense of who is truly in control of Liaoning He Eye Hospital Group Co., LTD. (SZSE:301103), it is important to understand the ownership structure of the business. With 38% stake, individual insiders possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

了解誰真正控制了遼寧和眼科醫院集團有限公司(深圳證券交易所代碼:301103),了解企業的所有權結構很重要。個人內部人士持有38%的股份,是公司的最大股份。換句話說,該集團將從對公司的投資中獲得最多(或損失最大)。

As a result, insiders scored the highest last week as the company hit CN¥4.3b market cap following a 9.7% gain in the stock.

結果,內部人士上週得分最高,該公司的市值在股價上漲9.7%後達到43億元人民幣。

Let's delve deeper into each type of owner of Liaoning He Eye Hospital Group, beginning with the chart below.

讓我們從下圖開始,深入研究遼寧和眼科醫院集團的每種類型的所有者。

ownership-breakdown
SZSE:301103 Ownership Breakdown May 8th 2024
SZSE: 301103 所有權明細 2024 年 5 月 8 日

What Does The Institutional Ownership Tell Us About Liaoning He Eye Hospital Group?

關於遼寧河眼科醫院集團,機構所有權告訴我們什麼?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

機構在向自己的投資者報告時通常會根據基準來衡量自己,因此,一旦股票被納入主要指數,他們通常會對股票更加熱情。我們預計大多數公司都會有一些機構在冊,尤其是在它們正在成長的情況下。

We can see that Liaoning He Eye Hospital Group does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Liaoning He Eye Hospital Group, (below). Of course, keep in mind that there are other factors to consider, too.

我們可以看到,遼寧河眼科醫院集團確實有機構投資者;他們持有該公司很大一部分股票。這意味着在這些機構工作的分析師已經看過這隻股票,他們很喜歡。但是就像其他人一樣,他們可能錯了。如果兩個大型機構投資者試圖同時拋售股票,股價大幅下跌的情況並不少見。因此,值得一看遼寧和眼科醫院集團過去的盈利軌跡(見下圖)。當然,請記住,還有其他因素需要考慮。

earnings-and-revenue-growth
SZSE:301103 Earnings and Revenue Growth May 8th 2024
SZSE: 301103 收益和收入增長 2024 年 5 月 8 日

Hedge funds don't have many shares in Liaoning He Eye Hospital Group. The company's CEO Wei He is the largest shareholder with 19% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 12% and 7.7%, of the shares outstanding, respectively.

對沖基金在遼寧和眼科醫院集團的股份不多。該公司首席執行官何偉是最大股東,已發行股份的19%。同時,第二和第三大股東分別持有已發行股份的12%和7.7%。

To make our study more interesting, we found that the top 5 shareholders control more than half of the company which implies that this group has considerable sway over the company's decision-making.

爲了使我們的研究更有趣,我們發現前五名股東控制着公司一半以上的股份,這意味着該集團對公司的決策具有相當大的影響力。

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. As far as we can tell there isn't analyst coverage of the company, so it is probably flying under the radar.

研究機構所有權是衡量和篩選股票預期表現的好方法。通過研究分析師的情緒也可以達到同樣的目的。據我們所知,沒有分析師對該公司進行報道,因此它可能處於雷達之下。

Insider Ownership Of Liaoning He Eye Hospital Group

遼寧和眼科醫院集團的內部所有權

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

公司內部人員的定義可能是主觀的,並且在不同的司法管轄區之間確實有所不同。我們的數據反映了個人內部人士,至少涵蓋了董事會成員。公司管理層經營業務,但首席執行官將對董事會負責,即使他或她是董事會成員。

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

大多數人認爲內部所有權是積極的,因爲這可能表明董事會與其他股東關係良好。但是,在某些情況下,過多的權力集中在該群體中。

It seems insiders own a significant proportion of Liaoning He Eye Hospital Group Co., LTD.. It has a market capitalization of just CN¥4.3b, and insiders have CN¥1.7b worth of shares in their own names. This may suggest that the founders still own a lot of shares. You can click here to see if they have been buying or selling.

看來內部人士擁有遼寧和眼科醫院集團有限公司的很大一部分股份。它的市值僅爲43億元人民幣,內部人士以自己的名義持有價值17億元人民幣的股票。這可能表明創始人仍然擁有大量股份。你可以點擊這裏查看他們是否在買入或賣出。

General Public Ownership

一般公有制

With a 20% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Liaoning He Eye Hospital Group. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

遼寧和眼科醫院集團擁有 20% 的所有權,大衆對遼寧和眼科醫院集團有一定程度的影響力,主要是個人投資者。這種所有權規模雖然可觀,但如果決策與其他大股東不同步,可能不足以改變公司政策。

Private Equity Ownership

私募股權所有權

Private equity firms hold a 12% stake in Liaoning He Eye Hospital Group. This suggests they can be influential in key policy decisions. Sometimes we see private equity stick around for the long term, but generally speaking they have a shorter investment horizon and -- as the name suggests -- don't invest in public companies much. After some time they may look to sell and redeploy capital elsewhere.

私募股權公司持有遼寧和眼科醫院集團12%的股份。這表明他們可以在關鍵政策決策中發揮影響力。有時我們會看到私募股權長期存在,但總的來說,它們的投資期限較短,而且顧名思義,對上市公司的投資並不多。一段時間後,他們可能會考慮出售資本並將其重新部署到其他地方。

Private Company Ownership

私人公司所有權

Our data indicates that Private Companies hold 12%, of the company's shares. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

我們的數據表明,私營公司持有公司12%的股份。可能值得對此進行更深入的研究。如果內部人士等關聯方對其中一傢俬營公司感興趣,則應在年度報告中披露。私營公司也可能在公司中擁有戰略利益。

Public Company Ownership

上市公司所有權

Public companies currently own 5.0% of Liaoning He Eye Hospital Group stock. This may be a strategic interest and the two companies may have related business interests. It could be that they have de-merged. This holding is probably worth investigating further.

上市公司目前擁有遼寧和眼科醫院集團5.0%的股份。這可能是戰略利益,兩家公司可能有相關的商業利益。可能是他們已經消失了。這一裁定可能值得進一步調查。

Next Steps:

後續步驟:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. For example, we've discovered 3 warning signs for Liaoning He Eye Hospital Group (2 are potentially serious!) that you should be aware of before investing here.

我覺得看看究竟誰擁有一家公司非常有趣。但是,要真正獲得見解,我們還需要考慮其他信息。例如,我們發現了遼寧和眼科醫院集團的3個警告信號(2個可能很嚴重!)在這裏投資之前,您應該注意這一點。

Of course this may not be the best stock to buy. So take a peek at this free free list of interesting companies.

當然,這可能不是最值得買入的股票。因此,來看看這份免費的有趣公司名單吧。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是使用過去十二個月的數據計算得出的,這些數據是指截至財務報表日期當月最後一天的12個月期間。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論